Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07575932 · ClinicalTrials.gov registry record · Phase 2
A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1)
A Phase 2 study, sponsored by Pfizer.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 872
- Enrollment target
NCT07575932 is a Phase 2 study that is actively recruiting participants, run by Pfizer. The registered enrollment target is 872 participants.
The verdict
NCT07575932, a Phase 2 study, is actively recruiting participants, sponsored by Pfizer.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 872 participants
- Enrollment target
Study Summary
This study is being done to learn about the safety and effects of the study drugs, PF-08653945 and PF-08653944, when given alone or together for weight loss, compared to a placebo (a dummy drug that has no active ingredient in it).
Interventions
- DRUG Placebo
- DRUG PF-08653944
- DRUG PF-08653945
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 872 participants |
| Start Date | 2026-05-11 |
| Est. Completion | 2028-01-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07575932
The ClinicalTrials.gov registry entry for NCT07575932 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 872 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT07575932 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07575932 about?
NCT07575932 is a clinical study titled "A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1)". This study is being done to learn about the safety and effects of the study drugs, PF-08653945 and PF-08653944, when given alone or together for weight loss, compared to a placebo (a dummy drug that has no active ingredient in it).
What is the current status of trial NCT07575932?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 872 participants. The study started on 2026-05-11. Estimated completion is 2028-01-05.
What interventions are being tested in trial NCT07575932?
The interventions under investigation include: Placebo (DRUG), PF-08653944 (DRUG), PF-08653945 (DRUG).
Who is sponsoring clinical trial NCT07575932?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.